logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Glaxosmithkline Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Multinational
    BSE Code
    ISIN Demat
    Book Value()
    500660
    INE159A01016
    98.8545682
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    GLAXO
    50.19
    42500.59
    EPS(TTM)
    Face Value()
    Div & Yield %:
    49.99
    10
    1.28
     
Date Headline
18-Feb-2025 Glaxosmithkline Pharmaceuticals Ltd - Rumour verification - Regulation 30(11)
17-Feb-2025 Volumes jump at LMW Ltd counter
17-Feb-2025 Sandur Manganese & Iron Ores Ltd leads gainers in 'A' group
17-Feb-2025 Volumes jump at Ramkrishna Forgings Ltd counter
17-Feb-2025 Glaxosmithkline Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
17-Feb-2025 Glaxosmithkline Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Feb-2025 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Outcome of Board Meeting
17-Feb-2025 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Copy of Newspaper Publication
17-Feb-2025 Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
14-Feb-2025 Glaxosmithkline Pharmaceuticals consolidated net profit rises 402.80% in the December 2024 quarter
1 2 3 4 5  ...